Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered Probiotic Saccharomyces boulardii Reduces Colitis-Associated Colorectal Cancer Burden in Mice

Digestive Diseases and Sciences(2025)10.1007/s10620-025-09008-9Source: DataRank Database

Engineered Probiotic Saccharomyces boulardii Reduces Colitis-Associated Colorectal Cancer Burden in Mice is a research paper published in Digestive Diseases and Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 8.78)OA: greenTopics (55)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Krithika Senthil,Jessica Vlcek,Anthony Hazelton,Mairead K. Heavey ORCID,Rani S. Sellers ORCID

Live enrichment

PubMed:40156662 OpenAlex:https://openalex.org/W4409039175

National Institutes of Health,United States

Grant: T32DK07737

National Institutes of Health

Grant: T32GM086330

National Institutes of Health

Grant: T32GM135095

National Institutes of Health

Grant: R01DK124617

National Institutes of Health

Grant: 5T32GM086330-08

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

National Institutes of Health

Grant: 3P30CA016086-42S2

Cancer Center Support Grant

National Institutes of Health

Grant: 5P40OD010995-18

National Gnotobiotic Rodent Resource Center

National Institutes of Health

Grant: 2T32DK007737-06

Gastroenterology Research Training

National Institutes of Health

Grant: 1T32GM135095-01

Predoctoral Training in the Pharmacological Sciences

National Institutes of Health

Grant: 5R01DK124617-05

Microbiota-mediated fibrotic remodeling in the inflamed intestine

National Institutes of Health

Grant: 5P30AI050410-05

UNC Center for Aids Research

National Institutes of Health

Grant: 5P30DK034987-28

Administrative Core and Enrichment Program

NIH HHS

Grant: P40 OD010995

NIDDK NIH HHS

Grant: P30 DK034987

NCI NIH HHS

Grant: P30 CA016086

NIDDK NIH HHS

Grant: T32 DK007737

NIAID NIH HHS

Grant: P30 AI050410

FWCI

8.78

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://cdr.lib.unc.edu/downloads/zp38ww025

publisherhttps://link.springer.com/content/pdf/10.1007/s10620-025-09008-9.pdf

publisherhttps://link.springer.com/article/10.1007/s10620-025-09008-9/fulltext.html

repositoryhttps://doi.org/10.17615/jw5j-dw89

Fields of Study

Probiotics and Fermented FoodsCancer Research and TreatmentsGut microbiota and health0301 basic medicine03 medical and health sciencesAnimalsProbioticsSaccharomyces boulardiiMiceColitis-Associated NeoplasmsMice, Inbred C57BLDisease Models, AnimalColitisAzoxymethaneColorectal NeoplasmsMice, KnockoutTumor Burden

MeSH Terms

Saccharomyces boulardiiColitis-Associated NeoplasmsAnimalsAzoxymethaneColitisDisease Models, AnimalMice, Inbred C57BLColorectal NeoplasmsMice, KnockoutProbioticsTumor BurdenMice

Keywords

Saccharomyces boulardiiMedicineInflammationAzoxymethaneColorectal cancerCancerColitisInflammatory bowel diseaseImmunologyTumor necrosis factor alphaInternal medicineProbioticBiologyDiseaseMice, KnockoutProbioticsTumor BurdenMice, Inbred C57BLMiceDisease Models, AnimalAnimalsColitis-Associated NeoplasmsColorectal NeoplasmsColitis-associated cancerInflammatory bowel diseasesLive biotherapeutic

Sustainable Development Goals

SDG 0: Good health and well-being